type here...

CATEGORIES

Pharmaceutics

LATEST

1...789...11Page 8 of 11

TRENDING

EDITORS CHOICE

Ivermectin is NOT Hydroxychloroquine. Why is the FDA Ignoring a Potential Covid Treatment?

Robert Turner, Founding Editor -
Ivermectin has shown promise as a potential treatment. It needs to be urgently evaluated under the guidance of the FDA

This Is Why We Should NEVER Rush A Vaccine To Market

Dr. Hesham A. Hassaballa -
We need a vaccine for Covid-19. It is a matter of life and death. At the same time, that vaccine has to be proven to be safe and effective

Reblozyl (luspatercept) Approved for Treatment of Transfusion-Dependent Anemia

Medika Life -
European Commission Approves Reblozyl (luspatercept) for the Treatment of Transfusion-Dependent Anemia in Adult Patients with Myelodysplastic Syndromes or Beta Thalassemia

Drug Shortages During the Time of Coronavirus

Jennifer Mittler-Lee B.S. Pharma -
An astonishing 82% of drug shortages are listed as reason unknown. The other causes include manufacturing, discontinuation, raw materials, and supply and demand.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories